BLAC — Shareholder Vote
Bellevue Life Sciences Acquisition Corp. · 2025-02-13
The Nasdaq Proposal
Vote type
business combination
Outcome
passed
Shares for
2,175,065
Shares against
4,318
Shares redeemed
57,821
Amount redeemed
—
Price / share
—
Shares remaining
—
Data sourced from SEC EDGAR filings. Dates reflect the vote/event date as disclosed in the filing. Outcomes updated when follow-up filings are published.